Patents by Inventor Pratisksha Patel

Pratisksha Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibodies to the fibronectin binding protein and method of use in treating or preventing infections
    Patent number: 7115264
    Abstract: Monoclonal antibodies which can bind to the Fnbp protein of Staphylococcus aureus and which are generated from a peptide from the D2 region of fibronectin binding protein B (Fnbp) of S. aureus are provided which can be useful in the treatment and protection against infection from staphylococcal bacteria such as Staphylococcus aureus. The monoclonal antibodies of the invention are advantageous in that they bind S. aureus in high affinity and thus can be useful in the prevention of the adherence of staph bacteria to host cells by impairing or inhibiting the ability of S. aureus Fnbp to bind to fibronectin. Kits and methods of utilizing the monoclonal antibodies of the invention are also provided.
    Type: Grant
    Filed: November 5, 2002
    Date of Patent: October 3, 2006
    Assignee: INHIBITEX
    Inventors: Joseph M. Patti, Pratisksha Patel, Andrea Hall, Paul Domanski, Peter Syribeys, Jeff T. Hutchins
  • Monoclonal antibodies to the fibronectin binding protein and method of use in treating or preventing infections
    Publication number: 20030153022
    Abstract: Monoclonal antibodies which can bind to the Fnbp protein of Staphylococcus aureus and which are generated from a peptide from the D2 region of fibronectin binding protein B (Fnbp) of S. aureus are provided which can be useful in the treatment and protection against infection from staphylococcal bacteria such as Staphylococcus aureus. The monoclonal antibodies of the invention are advantageous in that they bind S. aureus in high affinity and thus can be useful in the prevention of the adherence of staph bacteria to host cells by impairing or inhibiting the ability of S. aureus Fnbp to bind to fibronectin. Kits and methods of utilizing the monoclonal antibodies of the invention are also provided.
    Type: Application
    Filed: November 5, 2002
    Publication date: August 14, 2003
    Inventors: Joseph M. Patti, Pratisksha Patel, Andrea Hall, Paul Domanski, Peter Syribeys, Jeff T. Hutchins